SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,515,000 | -40.4% | 109,000 | -31.3% | 0.24% | -17.2% |
| Q4 2021 | $14,282,000 | +385.6% | 158,600 | +398.7% | 0.29% | +225.8% |
| Q3 2021 | $2,941,000 | +26.1% | 31,800 | +6.0% | 0.09% | +7.2% |
| Q2 2021 | $2,332,000 | -8.0% | 30,000 | -11.8% | 0.08% | +31.7% |
| Q1 2021 | $2,534,000 | -70.9% | 34,000 | -33.5% | 0.06% | -62.0% |
| Q4 2020 | $8,712,000 | +41.0% | 51,100 | +16.1% | 0.17% | -27.5% |
| Q3 2020 | $6,180,000 | +492.5% | 44,000 | +576.9% | 0.23% | +218.1% |
| Q2 2020 | $1,043,000 | -36.3% | 6,500 | -56.7% | 0.07% | -83.0% |
| Q4 2018 | $1,637,000 | +929.6% | 15,000 | +328.6% | 0.42% | +1043.2% |
| Q3 2017 | $159,000 | – | 3,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |